Virpax Pharmaceuticals Correlations

VRPX Stock

USD 1.94 0.13 6.28%

The correlation of Virpax Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Virpax Pharmaceuticals Correlation With Market

Significant diversification

The correlation between Virpax Pharmaceuticals and DJI is 0.09 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Virpax Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Virpax Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Virpax Stock please use our How to Invest in Virpax Pharmaceuticals guide.

Moving together with Virpax Stock

0.82	CDIOW	Cardio Diagnostics	Pair Corr
0.66	ELVN	Enliven Therapeutics	Pair Corr
0.79	SCLX	Scilex Holding	Pair Corr
0.9	ASMB	Assembly Biosciences Earnings Call Tomorrow	Pair Corr
0.69	CDIO	Cardio Diagnostics	Pair Corr
0.75	CMND	Clearmind Medicine Common	Pair Corr
0.69	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.71	DIS	Walt Disney	Pair Corr
0.74	MSFT	Microsoft Aggressive Push	Pair Corr

Moving against Virpax Stock

0.76	WM	Waste Management	Pair Corr
0.75	LUCD	Lucid Diagnostics	Pair Corr
0.64	GE	GE Aerospace	Pair Corr
0.5	PG	Procter Gamble	Pair Corr
0.42	PLX	Protalix Biotherapeutics	Pair Corr
0.85	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.81	T	ATT Inc Sell-off Trend	Pair Corr
0.72	XOM	Exxon Mobil Corp Earnings Call This Week	Pair Corr
0.71	CVX	Chevron Corp	Pair Corr
0.69	MMM	3M Company	Pair Corr
0.58	IBM	International Business	Pair Corr
0.53	INTC	Intel Sell-off Trend	Pair Corr
0.41	CSCO	Cisco Systems	Pair Corr

Related Correlations Analysis

	PBLA	REVB	PALI	VRAX	QNRX	ZIVO	RNXT	KTTA	ABIO	NTRB
PBLA		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	PBLA
REVB	0.0		0.82	0.84	0.86	0.0	0.62	0.75	0.0	-0.62	REVB
PALI	0.0	0.82		0.79	0.87	0.0	0.78	0.94	0.0	-0.64	PALI
VRAX	0.0	0.84	0.79		0.71	0.0	0.67	0.75	0.0	-0.39	VRAX
QNRX	0.0	0.86	0.87	0.71		0.0	0.61	0.82	0.0	-0.8	QNRX
ZIVO	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	ZIVO
RNXT	0.0	0.62	0.78	0.67	0.61	0.0		0.87	0.0	-0.29	RNXT
KTTA	0.0	0.75	0.94	0.75	0.82	0.0	0.87		0.0	-0.53	KTTA
ABIO	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	ABIO
NTRB	0.0	-0.62	-0.64	-0.39	-0.8	0.0	-0.29	-0.53	0.0		NTRB
	PBLA	REVB	PALI	VRAX	QNRX	ZIVO	RNXT	KTTA	ABIO	NTRB

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

KTTA	+ 0.94	PALI
QNRX	+ 0.87	PALI
KTTA	+ 0.87	RNXT
QNRX	+ 0.86	REVB
VRAX	+ 0.84	REVB
PALI	+ 0.82	REVB

High negative correlations

NTRB	- 0.8	QNRX
NTRB	- 0.64	PALI
NTRB	- 0.62	REVB
NTRB	- 0.53	KTTA
NTRB	- 0.39	VRAX
NTRB	- 0.29	RNXT

Risk-Adjusted Indicators

There is a big difference between Virpax Stock performing well and Virpax Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Virpax Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
PBLA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
REVB	5.64	(0.57)	0.00	(1.12)	0.00	0.00	11.78	(12.26)	66.25
PALI	4.35	(1.29)	0.00	(3.49)	0.00	0.00	11.70	(10.84)	30.79
VRAX	6.28	0.06	0.02	(0.08)	6.90	(8.09)	16.67	(11.98)	59.66
QNRX	5.38	(0.85)	0.00	1.79	0.00	0.00	14.29	(10.53)	57.78
ZIVO	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
RNXT	3.40	(0.08)	0.00	(0.13)	0.00	0.00	7.37	(8.04)	30.92
KTTA	5.05	(0.78)	0.00	(0.43)	0.00	0.00	8.14	(10.75)	53.63
ABIO	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NTRB	6.04	1.08	0.18	0.63	5.27	(7.40)	17.09	(8.63)	54.72

Virpax Pharmaceuticals Corporate Management

CPA CPA	CFO Sec	Profile
Jeffrey MD	Chief VP	Profile
JD MBA	Chief Officer	Profile
Usama Chaudhry	Chief Officer	Profile
Shana Panzarella	Chief Staff	Profile
Anthony MBA	Chairman CEO	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC